New York, NY – The Dubin Breast Center of The Tisch Cancer Institute at The Mount Sinai Medical Center has become one of the first centers in the country to offer tomosynthesis, a breakthrough technology in the diagnosis of breast cancer.
Breast tomosynthesis is a revolutionary technology that produces sharp 3D images, facilitating the radiologists’ ability to clearly identify and characterize individual breast structures, allowing for earlier and more accurate diagnosis.
Conventional mammography is two-dimensional, and may not detect small cancers that are hidden by overlapping tissue. During a tomosynthesis exam, however, multiple, low-dose images of the breast are acquired at different angles. These images are then used to build a series of one-millimeter-thick slices into a 3D reconstruction of the breast. Because the problem of overlapping tissue is all but eliminated, tomosynthesis can make a tumor more visible and easier for a radiologist to see.
“Our goal is to make the patient experience at the Dubin Breast Center as smooth as possible,” says Laurie Margolies, MD, FACR, Associate Professor of Radiology, and Chief of Breast Imaging at The Mount Sinai Medical Center. “Tomosynthesis provides a 3D image, which can prove that an area that looked questionable in a traditional mammogram is normal tissue. This leads to fewer callbacks and less anxiety for our patients. We are pleased to be leading the charge by offering this cutting-edge technology in a clinical setting.”
By offering tomosynthesis, the Dubin Breast Center aims to increase the number of women being screened, and provide earlier and more accurate detection. Breast cancer is the second leading cause of cancer death among women, exceeded only by lung cancer. Statistics indicate that one in eight women will develop breast cancer sometime in her lifetime. The stage at which breast cancer is detected influences a woman’s chance of survival. If detected early, the five-year survival rate is 97 percent.
Encompassing more than 15,000 square feet at 1176 Fifth Avenue, the Dubin Breast Center represents a bold new vision for breast cancer treatment and research—one that focuses on the emotional, as well as the physical health of individuals who have or are at risk of developing breast cancer, as well as survivors and their families. The new Center is led by Co-Directors Elisa Port, MD, FACS, Chief of Breast Surgery, and George Raptis, MD, MBA, Associate Professor of Medicine in the Division of Hematology/Oncology, Mount Sinai School of Medicine, and is the only such center located within an academic medical institution in New York City.
The Center also includes an evaluation and treatment center for breast medical oncology and an infusion center for chemotherapy. Additional services include screening, genetic and nutritional counseling, breast reconstruction, psychosocial support and other complementary services, such as massage therapy, for the patient and his or her family.
For more information about the Dubin Breast Center, visit www.dubinbreastcenter.org.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of few medical schools embedded in a hospital in the United States. It has more than 3,400 faculty in 32 departments and 15 institutes, and ranks among the top 20 medical schools both in National Institute of Health funding and by U.S. News & World Report. The school received the 2009 Spencer Foreman Award for Outstanding Community Service from the Association of American Medical Colleges.
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation’s oldest, largest and most-respected voluntary hospitals. U.S. News & World Report consistently ranks The Mount Sinai Hospital among the nation’s best hospitals based on reputation, patient safety, and other patient-care factors. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 530,000 outpatient visits took place.
For more information, visit http://www.mountsinai.org/.